The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  Alnylam Pharmaceuticals Inc. (ALNY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Long on RNAi Science

Jul 17, 2007 01:41 PM GMT
Nhl_g_kopitar_275
Return Risk
-33.80% HIGH
Analyst

Product Review  

RNAi is a great technology that will create a great drug pipeline.  Alnylam is at the forefront, as is Sirna, which I would have bought had I done my proper research and Merck beat me to the punch with an acquisiton.

The risk here is classic biotech risk - can they actually produce working/approvable therapeutics and how much cash will it take to get them there?

This is a long-term hold - ALNY will have volatility, but is an option with tons of upside at the end of the day.

ALNY:  This call was made on 07/17/07 @ $23.49
Rating:   Positive   $23.49 (07/17/07)
Gain/Loss:   -33.80% in 847 days
Target:   in > one year


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.57% 370
2 Gerald Greene 18.14 +68.57% 207
3 stockmarketfunding.com 17.66 +25.68% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +77.15% 35


POPULAR STOCKS
Symbol Company Name Sentiment
AIG American International Group Inc.
WM Washington Mutual Inc
BIDU Baiducom Inc ADS
BAC Bank of America Corp
BA The Boeing Company
GE General Electric Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Alnylam Pharmaceuticals Inc. (ALNY)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
85.5%
Top:
100.0%




Latest Picks by benc
Symbol SP Sentiment Rating Return Since

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch